The enteral feeding devices market in the Middle East and Africa was worth USD 0.18 billion in 2023. The regional market is estimated to grow at a CAGR of 4.19% from 2023 to 2028 and will be worth USD 0.23 billion by 2028. Enteral nutrition is growingly being accepted as an effective system of clinical nutrition.
A notable shift from routine hospital care to non-clinical enteral nutrition in the home setting majorly drives the enteral feeding devices market in MEA and this trend is significantly impacting the healthcare sector as the rising costs of hospital stays have prompted clinicians to encourage patients requiring long-term nutritional support to adopt enteral nutrition at home. Several countries in the region, including UAE, Bahrain, Turkey, and Egypt, have established dedicated nutrition teams to support patients receiving enteral nutrition at home. As a result, the demand for enteral nutrition is positively influencing the MEA market, particularly in the developed countries of the region. This shift presents a promising opportunity for businesses operating in the MEA enteral feeding market to capitalize on this trend and cater to the increasing demand for non-clinical enteral nutrition.
The growing aging population of the MEA region contributes to the growth of the MEA enteral feeding devices market. As per the United Nations Department of Economic and Social Affairs, in 2014, approximately 12.7% of the global population was aged. This demographic is at a higher risk of being diagnosed with various diseases, such as diabetes, vascular disease, stroke, cancer, dementia, arthritis, osteoporosis, circulatory failure and Parkinson's disease. As a result, the demand for enteral feeding devices is significantly higher among the elderly suffering from these conditions. The MEA region has a significant population of elderly individuals who are suffering from various diseases, leading to the growth of the regional market. Moreover, the increasing adoption of technological advancements in manufacturing effective enteral feeding devices in the MEA regions is expected to fuel the growth rate of the market.
However, the growth of the enteral feeding market in the Middle East and Africa is expected to be impeded during the forecast period by factors such as unfavorable reimbursement policies in many developing countries within the region. Moreover, reductions in federal funding and subsequent cuts to reimbursements for home care services are also noteworthy factors that are negatively affecting the market's growth trajectory in the region.
This research report on the Middle East and Africa enteral feeding devices market has been segmented and sub-segmented into the following categories:
By Product Type:
By End User:
During the forecast period, the enteral feeding devices market in the African region is expected to hold a considerable share of the MEA market and the growth of the regional market is primarily driven by factors such as the growing aging population, increasing awareness of enteral nutrition, higher incidence of premature births and the rapid development of healthcare facilities. In the Middle East market, significant developments in manufacturing techniques and task performance have enabled players to dominate the market's growth. This has further boosted demand and is expected to drive sustained growth in the coming years. As a result, numerous Middle Eastern countries are anticipated to offer attractive growth opportunities during the forecast period.
KEY MARKET PLAYERS:
Companies playing a major role in the MEA enteral feeding devices market profiled in this report are Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A.
The MEA enteral feeding devices market is anticipated to grow at a CAGR of 4.19% from 2023 to 2028.
The growing prevalence of chronic diseases such as cancer and diabetes, rising geriatric population, and advancements in enteral feeding technology majorly boost the market growth in Middle East and Africa.
Abbott Laboratories, Fresenius Kabi AG, B. Braun Melsungen AG, Nestlé Health Science, and Danone Nutricia are some of the notable companies in the MEA enteral feeding devices market.
UAE, Saudi Arabia, and South Africa are predicted to account for the major share of the MEA market during the forecast period.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org